HEART FAILURE - ADULT (HF) -> HF - Therapeutics and Pharmacology Abstracts

577 - Initial Experience in Adults with Complex Congenital Heart Disease Treated with Sacubitril/Valsartan for Heart Failure

Presentation Number
577
Speakers
Session Name
POSTER SESSION 1 - POSTER SESSION: Heart Failure - Adult
Date
Wed, Apr 22, 2020
Time
06:00 PM - 07:15 PM
Authors

Previous ePresentation
571 - Prevalence of Cognitive Impairment in Heart Transplant Waiting-List Patients in a Developing Country

Next ePresentations
581 - Remote Dielectric Sensing (ReDS) for a Safe Discharge in Patients with Acutely Decompensated Heart Failure: Rationale and Design of the ReDS-SAFE HF Study
582 - Donor Specific Antibodies after Heart Transplantation: Can They Be Treated?
586 - C-reactive Protein and Left Ventricular Thickness Can Predict Acute Cellular Rejection after Heart Transplant
587 - Dynamic Computed Tomography Perfusion for Diagnosis of Cellular Rejection after Heart Transplantation
596 - High Serum Phosphate is Associated with Increased Cardiac Allograft Vasculopathy and Adverse Cardiac Events Following Heart Transplantation
597 - Regional Variability of Cardiac Allograft Vasculopathy by Intravascular Ultrasound Assessment
598 - Pre-Transplant Collagen Vascular Disease as a Risk Factor for Increase in Cardiac Allograft Vasculopathy after Heart Transplantation
602 - Global Coronary Artery Flow Reserve after Heart Transplantation: Recipient or Donor Age-Driven?
605 - Donor-Transmitted Atherosclerosis and the Occurrence of Cardiac Antibody-Mediated Rejection Influenced on the Development of Cardiac Allograft Vasculopathy
607 - Assessment of Coronary Allograft Vasculopathy by Intravascular Ultrasound 6 Weeks and One Year after Heart Transplantation: A Single Center Study